Tandem Diabetes Care (TNDM) Net Margin (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Net Margin of 8.25% for Q1 2026, down 4312.82% on a QoQ basis from 0.19% in Q4 2025, and up 4746.0% year-over-year from 0.17% in Q1 2025.
Tandem Diabetes Care (TNDM) Net Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Net Margin history runs 14 years deep, the most recent figure standing at 8.25% for Q1 2026.
- Quarterly Net Margin rose 4746.0% year-over-year to 8.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.2% (up 951.0% YoY) and the FY2025 annual result came in at 20.17%, down 996.0% from the prior year.
- Net Margin was 8.25% for Q1 2026 at Tandem Diabetes Care, down from 0.19% in the prior quarter.
- Across five years, Net Margin topped out at 0.27% in Q4 2024 and bottomed at 73.15% in Q1 2023.
- A 5-year average of 18.31% and a median of 13.89% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin sank 6477 bps — and 2024, when it surged 5086 bps.
- Tandem Diabetes Care's Net Margin stood at 7.21% in 2022, then sank by 111 bps to 15.23% in 2023, then soared by 102 bps to 0.27% in 2024, then sank by 170 bps to 0.19% in 2025, then tumbled by 4313 bps to 8.25% in 2026.
- Business Quant data shows TNDM's Net Margin at 8.25% in Q1 2026, 0.19% in Q4 2025, and 8.49% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 8.01% |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 16.74% |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 3.87% |
| 10 | Tandem Diabetes Care | 1.15 Bn | 576.42 Mn | 136.79 Mn | -8.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.25% |
| Dec 31, 2025 | -0.19% |
| Sep 30, 2025 | -8.49% |
| Jun 30, 2025 | -21.78% |
| Mar 31, 2025 | -55.71% |
| Dec 31, 2024 | 0.27% |
| Sep 30, 2024 | -9.52% |
| Jun 30, 2024 | -13.89% |
| Mar 31, 2024 | -22.29% |
| Dec 31, 2023 | -15.23% |
| Sep 30, 2023 | -17.76% |
| Jun 30, 2023 | -18.25% |
| Mar 31, 2023 | -73.15% |
| Dec 31, 2022 | -7.21% |
| Sep 30, 2022 | -23.93% |
| Jun 30, 2022 | -7.52% |
| Mar 31, 2022 | -8.38% |
| Dec 31, 2021 | 5.13% |
| Sep 30, 2021 | 3.20% |
| Jun 30, 2021 | 2.32% |